Cargando…
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies
The emergence of Omicron sublineages impacts the therapeutic efficacy of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) monoclonal antibodies (mAbs). Here, we evaluate neutralization and antibody-dependent cellular cytotoxicity (ADCC) activities of 6 therapeutic mAbs against Delta...
Autores principales: | Bruel, Timothée, Stéfic, Karl, Nguyen, Yann, Toniutti, Donatella, Staropoli, Isabelle, Porrot, Françoise, Guivel-Benhassine, Florence, Bolland, William-Henry, Planas, Delphine, Hadjadj, Jérôme, Handala, Lynda, Planchais, Cyril, Prot, Matthieu, Simon-Lorière, Etienne, André, Emmanuel, Baele, Guy, Cuypers, Lize, Mouthon, Luc, Mouquet, Hugo, Buchrieser, Julian, Sève, Aymeric, Prazuck, Thierry, Maes, Piet, Terrier, Benjamin, Hocqueloux, Laurent, Schwartz, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706550/ https://www.ncbi.nlm.nih.gov/pubmed/36450283 http://dx.doi.org/10.1016/j.xcrm.2022.100850 |
Ejemplares similares
-
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection
por: Planas, Delphine, et al.
Publicado: (2022) -
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2022) -
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
por: Planas, Delphine, et al.
Publicado: (2023) -
Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2
por: Saunders, Nell, et al.
Publicado: (2022) -
Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2
por: Planchais, Cyril, et al.
Publicado: (2022)